Longevity Peptides

A tetrapeptide studied for its potential to activate telomerase and influence biological aging markers.

A thymic peptide approved in some countries for immune modulation, studied for viral infections and cancer adjunct therapy.

A mitochondrial-derived peptide studied for metabolic regulation, exercise mimetic effects, and longevity.

A mitochondria-targeted peptide FDA-approved as FORZINITY (elamipretide) for Barth syndrome in September 2025 — the first FDA-approved mitochondrial-targeted therapeutic.

A senolytic peptide designed to selectively clear senescent cells by disrupting FOXO4-p53 interaction.

A thymic peptide preparation studied for immune system rejuvenation and age-related immune decline.

A coenzyme essential for cellular energy production, studied for anti-aging and metabolic support.

A short bioregulatory peptide studied for neuroprotective effects and cognitive support in aging.

A naturally occurring longevity hormone (secreted alpha-klotho) being studied for cognition and brain aging; a single low-dose injection improved memory in aged monkeys, and a first-in-human Phase 1 trial in older adults is underway.

An endogenous mitochondrial-derived peptide studied for neuroprotection, cellular stress resistance, and longevity, whose blood levels fall with age and are elevated in centenarians.